Optic Neuritis Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Market is Segmented by Treatment Type (Steroidal Therapy, Immunomodulators Therapy, and Other Treatments) and Geography.

Market Snapshot

Optic Neuritis Treatment Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.1 %
Optic Neuritis Treatment Market Key players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The optic neuritis treatment market is expected to register a CAGR of 4.1% during the forecast period. Optic neuritis is inflammation of the optic nerve in which myelin covering is damaged by the inflammation, which typically results in blurred or dark vision. Some of the symptoms include pain, vision loss in one eye, visual field loss, loss of color vision, flashing or flickering lights with eye movements. Signs and symptoms of optic neuritis can be the first indication of multiple sclerosis or the disorder can occur later in the course of multiple sclerosis. Multiple sclerosis is a disease that causes inflammation and damage to nerves in the brain, as well as the optic nerve.

Optic neuritis disease can happen to anyone at any age, but most cases occur in women who are between the ages of 20 to 40. In addition, according to the Optic Neuritis Foundation Inc, an estimate of 15-20% of the people suffering from optic neuritis are likely to end up suffering from multiple sclerosis.

Rise in the geriatric population, increasing incidence of multiple sclerosis, and growing awareness about early detection of optic neuritis are the key driving factors of the optic neuritis treatment market.

Scope of the Report

Optic neuritis is inflammation of the optic nerve in which myelin covering is damaged by the inflammation, which typically results in blurred or dark vision. The optic neuritis treatment market is segmented by treatment type and geography.

By Treatment Type
Steroidal Therapy
Immunomodulators therapy
Other Treatment Types
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Steroidal Therapy Segment is Expected to Hold a Major Market Share in the Optic Neuritis Treatment Market

  • Steroidal therapy includes corticosteroid drugs used to treat optic neuritis, which have proven efficacy for decades.
  • According to the Optic Neuritis Foundation Inc, adults between the ages of 18-45 years are most prone to optic neuritis. Moreover, females are said to be more inclined to optic nerve inflammation as compared to males. However, only 3% of the population suffering from optic neuritis are expected to lose complete vision and go blind.
  • The steroidal therapy segment holds a significant market share in the optic neuritis treatment market. It is anticipated to show a similar trend over the forecast period due to the high efficacy and easy availability of the products.
  • Rise in the geriatric population, and growing awareness about early detection of optic neuritis associated with multiple sclerosis are the key driving factors in the steroidal therapy segment.
Optic Neuritis Treatment Market Trends

North America is Expected to Hold a Significant Share in the Market during the Forecast Period

North America is expected to hold a major market share in the global optic neuritis treatment market due to high disease prevalence, availability of reimbursement, and growing awareness among the population regarding multiple sclerosis and optic neuritis in this region and a study published in the Journal of Neurology stated that the annual incidence of optic neuritis in the United States is found to be around 5/1,000,000, with estimated prevalence 115/1,000,000. Furthermore, technological advancement and the launch of new treatment options, increasing healthcare spending, and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.

Optic Neuritis Treatment Market Growth

Competitive Landscape

The optic neuritis treatment market is fragmented competitive and consists of several major players. Some of the major players which are currently dominating the market are Pfizer Inc., Mallinckrodt Pharmaceuticals, Novartis AG, Teijin Pharmaceutical Limited, Biogen, Allergan PLC, Bristol-Myers Squibb Company, Healthy Life Pharma Private Limited, and AdvaCare Pharma.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Optic Neuritis

      2. 4.2.2 Favourable Reimbursement Policies

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects Associated with the Treatment

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Treatment Type

      1. 5.1.1 Steroidal Therapy

      2. 5.1.2 Immunomodulators therapy

      3. 5.1.3 Other Treatment Types

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Pfizer Inc.

      2. 6.1.2 Mallinckrodt Pharmaceuticals

      3. 6.1.3 Novartis AG

      4. 6.1.4 Teijin Pharmaceutical Limited

      5. 6.1.5 Biogen

      6. 6.1.6 Allergan PLC

      7. 6.1.7 Bristol-Myers Squibb Company

      8. 6.1.8 Healthy Life Pharma Private Limited

      9. 6.1.9 AdvaCare Pharma

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Optic Neuritis Treatment Market market is studied from 2018 - 2026.

The Optic Neuritis Treatment Market is growing at a CAGR of 4.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Biogen, Pfizer Inc, Mallinckrodt Pharmaceuticals, Novartis AG, Teijin Pharmaceutical Limited are the major companies operating in Optic Neuritis Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!